DE60027209D1 - Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen - Google Patents

Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen

Info

Publication number
DE60027209D1
DE60027209D1 DE60027209T DE60027209T DE60027209D1 DE 60027209 D1 DE60027209 D1 DE 60027209D1 DE 60027209 T DE60027209 T DE 60027209T DE 60027209 T DE60027209 T DE 60027209T DE 60027209 D1 DE60027209 D1 DE 60027209D1
Authority
DE
Germany
Prior art keywords
webble
bone
diseases
treatment
medicament contains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60027209T
Other languages
English (en)
Other versions
DE60027209T2 (de
Inventor
Vsevolod Nikolatvich Rudin
Vladimir Fedorovich Komarov
Igor Vitallevich Melikhov
Vladimir Vasillievich Minaev
Andrei Yurievich Orlov
Viktor Evgenievich Bozhevolnov
Aleksander Sergievic Pankratov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZAKRYTOE AKTSIONERNOE OBSCHESTVO OSTIM MOSKAU/MOSKVA
Original Assignee
ZAKRYTOE AKTSIONERNOE OBSCHESTVO OSTIM MOSKAU/MOSKVA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZAKRYTOE AKTSIONERNOE OBSCHESTVO OSTIM MOSKAU/MOSKVA filed Critical ZAKRYTOE AKTSIONERNOE OBSCHESTVO OSTIM MOSKAU/MOSKVA
Publication of DE60027209D1 publication Critical patent/DE60027209D1/de
Application granted granted Critical
Publication of DE60027209T2 publication Critical patent/DE60027209T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
    • A61L24/0084—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing fillers of phosphorus-containing inorganic compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60027209T 2000-09-12 2000-09-12 Behandlung von Knochengewebserkrankungen Expired - Lifetime DE60027209T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2000/001291 WO2002022117A1 (en) 2000-09-12 2000-09-12 Preparation for treating diseases of bone tissues

Publications (2)

Publication Number Publication Date
DE60027209D1 true DE60027209D1 (de) 2006-05-18
DE60027209T2 DE60027209T2 (de) 2007-01-04

Family

ID=11003972

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60027209T Expired - Lifetime DE60027209T2 (de) 2000-09-12 2000-09-12 Behandlung von Knochengewebserkrankungen

Country Status (6)

Country Link
US (1) US7387785B1 (de)
EP (1) EP1317261B1 (de)
AU (1) AU2000274383A1 (de)
DE (1) DE60027209T2 (de)
ES (1) ES2256039T3 (de)
WO (1) WO2002022117A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020115742A1 (en) * 2001-02-22 2002-08-22 Trieu Hai H. Bioactive nanocomposites and methods for their use
DE102009039665A1 (de) 2009-09-02 2011-03-03 Aap Biomaterials Gmbh Hydroxylapatitmaterial sowie Verfahren zu dessen Herstellung
DE102009043550A1 (de) 2009-09-30 2011-05-19 Aap Biomaterials Gmbh Knochenzement und Verfahren zu dessen Herstellung
EP2496240B1 (de) * 2009-11-06 2018-09-26 The Regents of the University of Michigan Zusammensetzungen aus apatit und verfahren zu ihrer verwendung
US10531908B2 (en) 2012-05-25 2020-01-14 Ojai Retinal Technology, Llc Method for heat treating biological tissues using pulsed energy sources
US10596389B2 (en) 2012-05-25 2020-03-24 Ojai Retinal Technology, Llc Process and system for utilizing energy to treat biological tissue
US9381116B2 (en) 2012-05-25 2016-07-05 Ojai Retinal Technology, Llc Subthreshold micropulse laser prophylactic treatment for chronic progressive retinal diseases
US9381115B2 (en) 2012-05-25 2016-07-05 Ojai Retinal Technology, Llc System and process for retina phototherapy
US10278863B2 (en) 2016-03-21 2019-05-07 Ojai Retinal Technology, Llc System and process for treatment of myopia
US10874873B2 (en) 2012-05-25 2020-12-29 Ojai Retinal Technology, Llc Process utilizing pulsed energy to heat treat biological tissue
US11077318B2 (en) 2012-05-25 2021-08-03 Ojai Retinal Technology, Llc System and process of utilizing energy for treating biological tissue
US10076671B2 (en) 2012-05-25 2018-09-18 Ojai Retinal Technology, Llc Apparatus for retina phototherapy
US9427602B2 (en) 2012-05-25 2016-08-30 Ojai Retinal Technology, Llc Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair
US10894169B2 (en) 2012-05-25 2021-01-19 Ojai Retinal Technology, Llc System and method for preventing or treating Alzheimer's and other neurodegenerative diseases
US9962291B2 (en) 2012-05-25 2018-05-08 Ojai Retinal Technology, Llc System and process for neuroprotective therapy for glaucoma
US9168174B2 (en) 2012-05-25 2015-10-27 Ojai Retinal Technology, Llc Process for restoring responsiveness to medication in tissue of living organisms
US10219947B2 (en) 2012-05-25 2019-03-05 Ojai Retinal Technology, Llc System and process for retina phototherapy
US10953241B2 (en) 2012-05-25 2021-03-23 Ojai Retinal Technology, Llc Process for providing protective therapy for biological tissues or fluids
US10709608B2 (en) 2016-03-21 2020-07-14 Ojai Retinal Technology, Llc System and process for prevention of myopia
GB201813928D0 (en) 2018-08-28 2018-10-10 Univ Sheffield Solid suspension

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1055481A1 (ru) * 1981-05-28 1983-11-23 Научно-Исследовательская Лаборатория Металлоостеосинтеза Им.А.Сеппо Способ лечени ложных суставов (его варианты)
US4668295A (en) * 1985-04-25 1987-05-26 University Of Dayton Surgical cements
JPS63270061A (ja) * 1987-04-28 1988-11-08 Hoya Corp 無機生体材料の表面改質方法
US5053212A (en) * 1988-04-20 1991-10-01 Norian Corporation Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite
US5573771A (en) * 1988-08-19 1996-11-12 Osteomedical Limited Medicinal bone mineral products
WO1995008304A1 (en) * 1993-09-21 1995-03-30 The Penn State Research Foundation Bone substitute composition comprising hydroxyapatite and a method of production therefor
RU94020019A (ru) * 1994-05-31 1996-11-27 Акционерное общество закрытого типа "ОСТИМ" Лекарственная пленка для лечения пародонтита
US6287341B1 (en) * 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US6027742A (en) * 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
JP4040705B2 (ja) * 1996-01-24 2008-01-30 株式会社サンギ 口腔組成物
US6143948A (en) * 1996-05-10 2000-11-07 Isotis B.V. Device for incorporation and release of biologically active agents
ES2180072T3 (es) * 1997-10-17 2003-02-01 Zakrytoe Aktsionernoe Obschest Composicion estomatica.
US7204874B2 (en) * 2001-10-24 2007-04-17 Pentron Clinical Technologies, Llc Root canal filling material
WO2003065996A2 (en) * 2002-02-05 2003-08-14 Cambridge Scientific, Inc. Bioresorbable osteoconductive compositions for bone regeneration
US6767955B2 (en) * 2002-05-08 2004-07-27 Pentron Clinical Technologies Flowable dental resin materials and method of use thereof

Also Published As

Publication number Publication date
EP1317261A1 (de) 2003-06-11
WO2002022117A1 (en) 2002-03-21
EP1317261B1 (de) 2006-04-05
AU2000274383A1 (en) 2002-03-26
ES2256039T3 (es) 2006-07-16
DE60027209T2 (de) 2007-01-04
US7387785B1 (en) 2008-06-17

Similar Documents

Publication Publication Date Title
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
FIU20060389U0 (fi) Luusairauksien hoito
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
DE60028863D1 (de) Elektrochirurgisches Handstück zur Behandlung von Gewebe
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE60232251D1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
DE60328476D1 (de) Medizinisches ballonsystem zur behandlung von adipositas
DE69840239D1 (de) Prothese zur chirurgischen behandlung der hernia
DE10085007T1 (de) Antiinfektionszusammensetzungen zur Behandlung von erkranktem Gewebe, wie Lippenherpes
DE60230425D1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60218375D1 (de) Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
DE60127552D1 (de) Intrakorporelle medikamente zur hoch-energetischen phototherapeutischen behandlung von krankheiten
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ATE312104T1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
NO20012106D0 (no) Middel for behandling av benpatobolisme
DE60223707D1 (de) Calcium-l-threonat zur behandlung von knochenfrakturen
ATE299371T1 (de) Antikonvulsiva zur behandlung von autismus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition